6-K ·Filed Aug 26, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001575872-26-000618
Actionable Insight • Neutral

This is a routine ESOP exercise notification with negligible dilution. No trading action warranted; monitor next quarterly filing for any material changes in share count or guidance.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
RDY ▼ -0.41% at T+5d
NEUTRAL call ✗ call lost -0.41% · α vs SPY -0.29% · entry $12.22 → $12.17
Next anchor: T+20d due 8d ago
Latest observation: T+18 +14.49% FF3 residual α
Entry anchored
Aug 26, 01:54 PM ET
via 1-min bar
T+1d
-0.49%
call -0.49% · α -1.15%
$12.16
settled 5w ago
T+5d
-0.41%
call -0.41% · α -0.29%
$12.17
settled 4w ago
T+20d
—
call — · α —
—
due 8d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's filed a routine 6-K on August 26, 2026, disclosing the allotment of 4,110 equity shares (Re. 1 par value) to employees upon exercise of stock options under the 2002 ESOP scheme. The total issued shares increased to 83,46,80,910. This is a standard administrative ESOP exercise notification with no material financial impact or strategic significance.

Key Facts

  • Allotted 4,110 equity shares (Re. 1 par value) on August 26, 2026 under Dr. Reddy's Employees Stock Options Scheme, 2002
  • Exercise price was Re. 1 per share, with nil premium
  • Total issued shares after allotment: 83,46,80,910
  • Total paid-up capital after issue: Rs. 83,46,79,910 (difference of 1,000 due to forfeited shares from 1988)

Financial Impact

Minimal — 4,110 shares represent approximately 0.00005% of total outstanding shares, with no premium received.

dilution

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
31% bullish (45 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (RDY) — Batch item 10001575872-26-000618
Document: 0001575872-26-000618-index.html0001575872-26-000618
Document: 0001575872-26-000618.txt0001575872-26-000618
6-K Filing (RDY) — Batch item 40001575872-26-000618
Document: 0001575872-26-000618-index.html0001575872-26-000618
Document: 0001575872-26-000618.txt0001575872-26-000618
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access